| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |